GlassScriptPhysician profile
Amy J Fraser
NPI 1104853241
$616.55
in general payments reported to CMS, 2019-2025
11 companies · $93.85 in 2025
The $93.85 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $123 · 2022: $186 · 2023: $107 · 2024: $106 · 2025: $93.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $307.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $144.72 | 2021-2025 | Eluvia, Ranger |
| Kerecis Limited | $116.08 | 2021-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Csl Behring | $106.67 | 2022 | |
| Janssen Pharmaceuticals, INC | $65.54 | 2022 | |
| Organogenesis INC. | $43.78 | 2023-2025 | Apligraf, Puraply |
| Neurocrine Biosciences, INC. | $35.11 | 2024 | Ingrezza |
| Pfizer INC. | $26.54 | 2021-2022 | |
| Lemaitre Vascular, INC. | $23.87 | 2025 | Pruitt F3 Carotid Shunt |
| Inspiremd LTD | $21.28 | 2025 | Cguard Prime Carotid Stent System |
| Bard Peripheral Vascular, INC. | $19.48 | 2023 | |
| Silk Road Medical, INC. | $13.48 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Fraser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.